Stellar Pharmaceuticals Hires New VP of Sales – Market Wire

Stellar also markets Bezalip®* SR (bezafibrate) NeoVisc® (1.0% sodium hyaluronate solution) and Uracyst® (sodium chondroitin sulfate solution 2%) in the Canadian market place and is awaiting regulatory approval for Cambia®** (diclofenac potassium for …

Leave a Reply

Your email address will not be published.

*